Mammalian Parasitic Vaccine: A Consolidated Exposition
Journal Title: Journal of Vaccines and Immunology - Year 2015, Vol 1, Issue 1
Abstract
Parasites are highly prevalent in livestock worldwide and infect over one fourth of the human population also. Parasites are successful in evading host immune responses, and vaccination can prove to be an effective way to control them. However, currently very few vaccines are available against parasitic infection. Two important limitations in the emergence of effective parasitic vaccines are incomplete understanding of the immunoregulatory pathways involved in immunity, and the lack of precise information regarding host-pathogen interactions. Precise identification of parasite genes and the role of their products in parasite biology may assist in the identification of useful antigens, which could then be produced in recombinant systems. Many recombinant parasitic antigens have been successfully used in livestock and new vaccines are under trail. Numerous vaccine antigens are defined to target a wide range of parasite species. Thus vaccines offer a green solution to control disease. Vaccines have multiple beneficial effects such as improvement of animal health and welfare by controlling animal infestations and infections; diminishing resistance to anthelmintics, acaricides and antibiotics; improving public health status by controlling food borne pathogens and zoonoses aspect related to animals; keeping animals and the environment free of chemical residues and maintaining biodiversity. This current review is an attempt to consolidate all commercial or under-trail vaccine for mammalian parasites.
Authors and Affiliations
Sumbria Deepak, Singla LD
Immunogenicity of Hydrolysate Formulas in Children (Part 1). Review of 202 Reactions
Cow's milk (CM) protein hydrolyzed formulas (HFs) appeared in the 40's with the aim of decreasing or eliminating the allergenicity of CM proteins, and in addition of reducing the risk of sensitization. In recent years th...
The Role of Endoplasmic Reticulum Aminopeptidase 1 Biology in Immune Evasion by Tumours
Expression of MHC I at the cell surface is essential for presenting peptides to circulating cytotoxic T cells. Interference with a number of components of the antigen processing machinery is an immune evasion mechanism t...
IMS 4112 and VLP of HBV as Th1 Adjuvants for a Recombinant Protein of HIV-1
Background: Current thinking suggests that vaccination approaches against the HIV-1 should be directed to elicit a Th1 cell-mediated immunity, neutralizing antibodies and/or ADCC mediating antibody responses. Also, exper...
Efficacy of a Recombinant Genotype VII Vaccine against Challenge with Velogenic Newcastle Disease Virus
Background: Newcastle disease virus (NDV) genotype VII has become the dominant genotype in China. However, NDV genotype II was used to make current commercial NDV vaccines. The mismatch of genotypes between circulating a...
Travel Vaccination
With increased globalization, the international boundaries between countries are diminished. Number of worldwide activities such as tourism, expansion of industry to multinational level, migrant employment, civilized eff...